U01.04.028 Tumor suppressor genes

Learning Objectives

Master the Tumor Suppressor Genes and the “Two-Hit Hypothesis.” Differentiate between the specific genes that regulate the cell cycle, inhibit growth signaling pathways, or maintain genomic stability. Understand how loss-of-function mutations in both alleles lead to specific hereditary and sporadic malignancies.


1. The Two-Hit Hypothesis

Unlike oncogenes, tumor suppressor genes generally follow the Knudson 2-hit hypothesis. This means both alleles must be inactivated to lose the “brakes” on cell division and increase cancer risk.

Associated Condition Tumor Suppressor Gene Gene Product / Function
Li-Fraumeni (SBLA) Syndrome TP53 p53; activates p21 to block G1 → S transition.
Retinoblastoma & Osteosarcoma RB1 pRb; inhibits E2F to block G1 → S transition.
FAP (Familial Adenomatous Polyposis) APC Negative regulator of β-catenin/WNT pathway.
Breast & Ovarian Cancers BRCA1 / BRCA2 DNA repair proteins.

 


2. Neuro-Cutaneous & Endocrine Suppressors

These genes are critical for regulating specific intracellular signaling cascades, such as the Ras and PI3K pathways.

Associated Condition Tumor Suppressor Gene Gene Product / Function
Neurofibromatosis type 1 NF1 Neurofibromin (Ras GTPase activating protein).
Neurofibromatosis type 2 NF2 Merlin (schwannomin) protein.
Tuberous Sclerosis TSC1 / TSC2 Hamartin and Tuberin (“2berin”).
MEN Type 1 MEN1 Menin.

Activity:


3. Organ-Specific Suppressors

Many tumor suppressors are named for the specific clinical syndrome or organ system they primarily impact.

Associated Condition Tumor Suppressor Gene Gene Product / Function
Wilms Tumor (Nephroblastoma) WT1 Urogenital development transcription factor.
von Hippel-Lindau Disease VHL Inhibits hypoxia-inducible factor 1α (HIF-1α).
Cowden Syndrome / Endometrial PTEN Negative regulator of PI3k/AKT pathway.
Pancreatic Cancer SMAD4 (DPC4) DPC = Deleted in Pancreatic Cancer.

 

Activity


High-Yield Mnemonics & Tips:

  • Li-Fraumeni (SBLA): Remember SBLA for the tumors associated with p53 mutations: Sarcoma, Breast/Brain, Lung/Leukemia, Adrenal.
  • DCC & DPC: These are easy to remember by their names: DCC = Deleted in Colorectal Cancer. DPC = Deleted in Pancreatic Cancer (SMAD4).
  • RB & the E2F: Think of Rb as the “security guard” holding onto E2F. When Rb is phosphorylated, it lets go of E2F, allowing the cell cycle to advance to the S-phase.

Activity: